首页 | 本学科首页   官方微博 | 高级检索  
     检索      

慢呼宁口服液对人工感染鸡慢性呼吸道病的治疗试验研究
引用本文:王贵波,谢家声,罗永江,郑继方,罗超应,辛蕊华,李锦宇,程龙.慢呼宁口服液对人工感染鸡慢性呼吸道病的治疗试验研究[J].中国畜牧兽医,2014,41(10):261-266.
作者姓名:王贵波  谢家声  罗永江  郑继方  罗超应  辛蕊华  李锦宇  程龙
作者单位:中国农业科学院兰州畜牧与兽药研究所, 甘肃兰州 730050
基金项目:“十二五”国家支撑计划(2011BAD34B03);科技部科研院所技术开发研究专项(2013EG134236);农业科技成果转化资金项目(2012GB23260560);中央级公益性科研院所基本科研业务费专项资金资助项目(1610322014021)
摘    要:为验证慢呼宁口服液对鸡慢性呼吸道病的治疗效果,将21日龄三黄肉鸡按常规方法随机分为6组,每组30只,分别为:慢呼宁口服液高、中(相当于推荐剂量)、低剂量组及镇喘散对照组、感染对照(感染不给药)组、健康对照组,除健康对照组外其余各组鸡均进行鸡毒支原体的人工感染。各药物治疗组连续给药7 d,停药后继续观察14 d,分别对其临床疗效、平均增重与病理变化等进行观察与评价。结果显示慢呼宁口服液高、中剂量组对感染鸡有明显的疗效,能明显降低血清抗体反应阳性率,气囊损伤减少率达90%以上,试验鸡的鸡毒支原体抗体阳性检出率为10%、20%,平均增重分别为596.1和661.3 g。而镇喘散对照组在气囊损伤减少率(82.5%)和平均增重方面较慢呼宁口服液中、高剂量组小,而鸡毒支原体抗体阳性检出率(30%)则较高。结果表明,慢呼宁口服液对鸡慢性呼吸道病有较好的防制效果,其作用优于镇喘散。

关 键 词:慢呼宁口服液  慢性呼吸道病  鸡毒支原体    
收稿时间:2014-05-04

Research on Manhuning Oral Liquid to Treat the Chicken Infected Artificially with Chronic Respiratory Disease
WANG Gui-bo,XIE Jia-sheng,LUO Yong-jiang,ZHENG Ji-fang,LUO Chao-ying,XIN Rui-hua,LI Jin-yu,CHENG Long.Research on Manhuning Oral Liquid to Treat the Chicken Infected Artificially with Chronic Respiratory Disease[J].China Animal Husbandry & Veterinary Medicine,2014,41(10):261-266.
Authors:WANG Gui-bo  XIE Jia-sheng  LUO Yong-jiang  ZHENG Ji-fang  LUO Chao-ying  XIN Rui-hua  LI Jin-yu  CHENG Long
Institution:Lanzhou Institute of Animal and Veterinary Pharmaceutics Sciences, Chinese Academy of Agricultural Sciences, Lanzhou 730050, China
Abstract:In order to verify the effect of Manhuning oral liquid on treating chronic respiratory disease in chickens,the 21-day-old Yellow broiler chickens were randomly divided into six groups (n=30) including high-dose group,middle-dose (equivalent to the recommended dose) group,low-dose group of Manhuning oral liquid and Zhenchuan power group,model group,the control group. The chickens in each group were artificially infected with Mycoplasma gallisepticum except to the control group. The chickens in each administration group were given the drug continuously for 7 days and then all of the chickens were observed for 14 d. The clinical efficacy,average weight gain and pathological changes were observed and evaluated,respectively. The results showed that the high-dose and middle-dose group of Manhuning oral liquid had an apparent effect on infected chickens and the serum Mycoplasma antibody-positive rate could be apparently reduced,while the rate of airbag injury reduction could be both above 90% and the positive rates of chickens' Mycoplasma antibody were 10% and 20%. Also the average weight gains were 596.1 and 661.3 g. In Zhenchuan power group,the rate of airbag injury reduction (82.5%) and the average weight gain were lower than the high-dose group and middle-dose group of Manhuning oral liquid,while the serum Mycoplasma antibody-positive rate (30%) was higher. The results showed that Manhuning oral liquid had good effect on prevention of the chronic respiratory disease in chicken,and its effect was better than the Zhenchuan power.
Keywords:Manhuning oral liquid  chronic respiratory disease  Mycoplasma gallisepticum  chicken  
点击此处可从《中国畜牧兽医》浏览原始摘要信息
点击此处可从《中国畜牧兽医》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号